Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving Doccla found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Doccla found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No recalls, safety notices, MHRA or CQC enforcement action involving Doccla found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
Apr 2025: NHS Greater Glasgow and Clyde awarded Doccla a £307k virtual ward contract. Jul 2025: South East London ICB announced its intention to award Doccla UK £1.3m for remote monitoring (initially COPD and asthma) over 30 months from Oct 2025, subject to standstill.